| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f312cc7676e939dee48fb4fdfe921ce8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
2016-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5f6a755c5b6b41be3989c3b8e0d7833
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d6429c78d3ca20f10fa33cfb834ad00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05c77cf5a589e33110ded02bd0444320
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af56468d75e17350a6acb2e8c7f4e69f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_482befc1721596b9a77866aec24796ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddb9fc13538e60d9cf69d78e72e59f3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_319cfbb5b2fa70404583c3060a80e142
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbc060829fbb8654220a8de94728cfcc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_702f78e8037d6a2cbeedf899257d1dcb |
| publicationDate |
2017-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-106496232-A |
| titleOfInvention |
1-(2-tetrahydropyran)-1H-pyrazolo[3,4-d]pyrimidine compound with antitumor activity and preparation method thereof |
| abstract |
The invention discloses a 1-(2-tetrahydropyran)-1H-pyrazolo[3,4-d]pyrimidine compound with antitumor activity, the general formula (I) of which is as follows. The invention also discloses a synthesis method of the compound and a pharmaceutical composition containing the compound. The invention also discloses the application of the pharmaceutical composition in treating diseases caused by abnormal protein kinase activity. The present invention develops a pyrazolo[3,4-d]pyrimidine compound with novel structure and significant anti-tumor activity. It has good effect and broad application prospect in diseases caused by abnormal protein kinase activity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112961158-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112961158-B |
| priorityDate |
2016-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |